{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:15:52Z","timestamp":1721088952167},"reference-count":3,"publisher":"American College of Physicians","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.acpjournals.org\/journal\/aim\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Intern Med"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.7326\/annals-24-00741-jc","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T21:01:04Z","timestamp":1719867664000},"page":"JC76","source":"Crossref","is-referenced-by-count":0,"title":["In grade C\/D erosive esophagitis, vonoprazan ranks highest among PPIs and P-CABs for healing and maintaining remission"],"prefix":"10.7326","volume":"177","author":[{"given":"Sander Veldhuyzen","family":"van Zanten","sequence":"first","affiliation":[{"name":"University of Alberta, Edmonton, Alberta, Canada (S.V.V.)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4285","reference":[{"key":"ANNALS-24-00741-R1","doi-asserted-by":"crossref","unstructured":"Laine L, Sharma P, Mulford DJ, et al. Pharmacodynamics and pharmacokinetics of the potassium-competitive acid blocker vonoprazan and the proton pump inhibitor lansoprazole in US subjects. Am J Gastroenterol. 2022;117:1158-1161. [PMID: 35294415]","DOI":"10.14309\/ajg.0000000000001735"},{"key":"ANNALS-24-00741-R2","doi-asserted-by":"crossref","unstructured":"Mbuagbaw L, Rochwerg B, Jaeschke R, et al. Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev. 2017;6:79. [PMID: 28403893]","DOI":"10.1186\/s13643-017-0473-z"},{"key":"ANNALS-24-00741-R3","doi-asserted-by":"crossref","unstructured":"Haruma K, Kinoshita Y, Yao T, et al. Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis. BMC Gastroenterol. 2023;23:139. [PMID: 37127558]","DOI":"10.1186\/s12876-023-02772-w"}],"container-title":["Annals of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.acpjournals.org\/doi\/pdf\/10.7326\/ANNALS-24-00741-JC","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.acpjournals.org\/doi\/full-xml\/10.7326\/ANNALS-24-00741-JC","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T21:16:33Z","timestamp":1721078193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.acpjournals.org\/doi\/10.7326\/ANNALS-24-00741-JC"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":3,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.7326\/ANNALS-24-00741-JC"],"URL":"https:\/\/doi.org\/10.7326\/annals-24-00741-jc","relation":{},"ISSN":["0003-4819","1539-3704"],"issn-type":[{"value":"0003-4819","type":"print"},{"value":"1539-3704","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}